TaiMed Biologics to Present TMB-365 Data at IDWeek 2026
The company will present findings from a single-dose escalation study of TMB-365 and on resistance in the TMB-365/TMB-380 maintenance regimen in people living with HIV.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.